Affinity of 1-aryl-1,2,3,4-tetrahydroisoquinoline derivatives to the ion channel binding site of the NMDA receptor complex

被引:45
作者
Ludwig, Matthias
Hoesl, Comelia E.
Hoefner, Georg
Wanner, Klaus T.
机构
[1] Univ Munich, Dept Pharm, Zentrum Pharmaforsch, D-81377 Munich, Germany
[2] Selectavet Dr Otto Fischer GMBH, D-83629 Weyarn Holzolling, Germany
关键词
N-methyl-D-aspartate receptor; PCP binding site; MK-801; tetrahydroisoquinolines;
D O I
10.1016/j.ejmech.2006.03.005
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 1-aryl-1,2,3,4-tetrahydroisoquinoline and 8-methyl-1-aryl-1,2,3,4-tetrahydroisoquinoline derivatives was evaluated for affinity to the PCP binding site of the NMDA receptor complex. The (S)-configurated tetrahydroisoquinoline derivative (S)-4e(.)HCl bearing a 2-methylphenyl substituent in position I of the heterocyclic ring system and a methyl group in position 8 was found to exhibit the highest affinity among the derivatives with a K-i-value of 0.0374 mu M In addition, this compound shows a remarkable enantioselectivity of binding by being almost 90 times more potent than the corresponding (R)-enantiomer (R)-4e(.)HCl. Additionally, a convenient and efficient synthetic approach to racemic 1-aryl-1,2,3,4-tetrahydroisoquinoline derivatives is described. (c) 2006 Elsevier SAS. All rights reserved.
引用
收藏
页码:1003 / 1010
页数:8
相关论文
共 37 条
[21]  
Ludwig M, 2003, HETEROCYCLES, V61, P299
[22]   3-HYDROXYPYRROLES AND 1H-PYRROL-3(2H)-ONES .3. PYRROLONES FROM PYROLYSES OF AMINOMETHYLENE MELDRUM ACID-DERIVATIVES - LOSS OF CHIRALITY AT THE SITE OF HYDROGEN TRANSFER [J].
MCNAB, H ;
MONAHAN, LC .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1988, (04) :869-873
[23]  
MELDRUM B, 1990, CEREBROVAS BRAIN MET, V2, P27
[24]   RECENT PROGRESS USING CHIRAL FORMAMIDINES IN ASYMMETRIC SYNTHESES [J].
MEYERS, AI .
TETRAHEDRON, 1992, 48 (13) :2589-2612
[25]   The role of N-methyl-D-aspartate (NMDA) receptors in pain:: A review [J].
Petrenko, AB ;
Yamakura, T ;
Baba, A ;
Shimoji, K .
ANESTHESIA AND ANALGESIA, 2003, 97 (04) :1108-1116
[26]  
Raith K, 2004, INT J CLIN PHARM TH, V42, P191
[27]  
REYNOLDS IJ, 1988, MOL PHARMACOL, V33, P581
[28]   EXCITOTOXICITY AND THE NMDA RECEPTOR [J].
ROTHMAN, SM ;
OLNEY, JW .
TRENDS IN NEUROSCIENCES, 1987, 10 (07) :299-302
[29]   CHARACTERIZATION OF THE BINDING OF [H-3] FR115427, A NOVEL NONCOMPETITIVE NMDA RECEPTOR ANTAGONIST, TO RAT-BRAIN MEMBRANES [J].
SHERRIFFS, HJ ;
SHIRAKAWA, K ;
KELLY, JS ;
OLVERMAN, HJ ;
KUNO, A ;
OKUBO, M ;
BUTCHER, SP .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1993, 247 (03) :319-324
[30]   Molecular biology and ontogeny of glutamate receptors in the mammalian central nervous system [J].
Simeone, TA ;
Sanchez, RM ;
Rho, JM .
JOURNAL OF CHILD NEUROLOGY, 2004, 19 (05) :343-360